Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
C 2.67 -0.13% 0.00
MBRX closed up 2.1 percent on Wednesday, November 20, 2024, on 71 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Gapped Up Strength -0.13%
50 DMA Support Bullish 1.97%
Crossed Above 20 DMA Bullish 1.97%
Pocket Pivot Bullish Swing Setup 1.97%
Calm After Storm Range Contraction 1.97%
Inside Day Range Contraction 1.97%
Gapped Up Strength 1.97%
Fell Below 20 DMA Bearish 5.82%
50 DMA Support Bullish 5.82%
Upper Bollinger Band Touch Strength 5.82%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 3 hours ago
Down 1% about 3 hours ago
Up 2% about 3 hours ago
Up 1% about 3 hours ago
Rose Above Previous Day's High 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Oncology Acute Myeloid Leukemia Chemotherapy Antineoplastic Drugs Blastoma Glioblastoma Stage Pharmaceutical Transcription Transcription Factors Refractory Acute Myeloid Leukemia Transcription Factor Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia

Is MBRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.75
52 Week Low 2.115
Average Volume 47,306
200-Day Moving Average 4.28
50-Day Moving Average 2.53
20-Day Moving Average 2.56
10-Day Moving Average 2.62
Average True Range 0.26
RSI (14) 52.83
ADX 21.98
+DI 26.39
-DI 12.62
Chandelier Exit (Long, 3 ATRs) 2.55
Chandelier Exit (Short, 3 ATRs) 3.07
Upper Bollinger Bands 2.88
Lower Bollinger Band 2.25
Percent B (%b) 0.67
BandWidth 24.55
MACD Line 0.04
MACD Signal Line 0.02
MACD Histogram 0.0155
Fundamentals Value
Market Cap 89.21 Million
Num Shares 33.4 Million
EPS -0.89
Price-to-Earnings (P/E) Ratio -3.00
Price-to-Sales 0.00
Price-to-Book 0.48
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.02
Resistance 3 (R3) 3.03 2.94 2.96
Resistance 2 (R2) 2.94 2.85 2.93 2.94
Resistance 1 (R1) 2.80 2.79 2.76 2.79 2.92
Pivot Point 2.71 2.71 2.68 2.70 2.71
Support 1 (S1) 2.57 2.62 2.53 2.56 2.42
Support 2 (S2) 2.48 2.56 2.47 2.40
Support 3 (S3) 2.34 2.48 2.38
Support 4 (S4) 2.33